Skip to content

Residential Ventilation Systems and Filtration for Asthma Control in Adults

Cost-effective Approaches to Upgrading Residential Mechanical Ventilation Systems to Control Indoor Pollutants of Both Indoor and Outdoor Origin and Improve Asthma-related Health Outcomes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06098287
Enrollment
51
Registered
2023-10-24
Start date
2017-01-01
Completion date
2020-11-30
Last updated
2023-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Pollution; Exposure

Keywords

Adult asthma, Home intervention, Mechanical ventilation, Air filtration, Indoor air pollution exposures

Brief summary

The goal of this study was to investigate the effectiveness of three common approaches to upgrading residential mechanical ventilation systems in existing homes for improving asthma-related health outcomes, reducing indoor pollutants of both indoor and outdoor origin, and maintaining adequate environmental conditions and ventilation rates in a cohort of adult asthmatics in existing homes in Chicago, IL.

Detailed description

The Breathe Easy Study utilized a quasi-randomized, within-subjects, parallel-group, pre-post intervention study design with four weeklong periods of indoor air quality (IAQ) and indoor environmental data collection for approximately one year before the installation of mechanical ventilation systems, followed by four weeklong periods of IAQ and indoor environmental data collection for approximately one year after the installation of mechanical ventilation systems, conducted from July 2017 through March 2020 in Chicago, IL. With the nature of a healthy home intervention study by installing residential mechanical ventilation systems within the timeframe, each participant received interventions in the middle of the study period, including continuous exhaust-only systems; intermittent powered central-fan-integrated-supply (CFIS) systems; or continuous balanced systems with an energy recovery ventilator. Thus, each participant served as their own control and there was no formal control group that did not receive intervention nor did they receive a sham/placebo intervention. Primary health outcome, asthma control, was assessed by using the Asthma Control Test (ACT) every month, and quality of life, stress, and other asthma-related health outcomes were assessed via the baseline and end-line surveys.

Interventions

DEVICEResidential mechanical ventilation system (Exhaust)

Exhaust-only ventilation system

DEVICEResidential mechanical ventilation system (CFIS) and air filtration upgrades

Central-fan-integrated-supply ventilation system and air filtration upgrades (MERV 10)

DEVICEResidential mechanical ventilation system (ERV) and air filtration upgrades

Balanced energy recovery ventilation system and air filtration upgrades (MERV 10)

Sponsors

Elevate
CollaboratorUNKNOWN
Illinois Institute of Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A quasi-randomized, within-subjects, parallel-group, pre-post intervention study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age: 18 - 90+ years. * English speaking and writing. * Able to provide consent. * Chicago resident. * Households with at least one occupant with asthma * Non-smoking houses * Participant-owned houses * Participant's agreement to surveys and IAQ monitoring over 2 years

Exclusion criteria

* Houses outside Chicago, IL USA * Houses with significant health and safety issues

Design outcomes

Primary

MeasureTime frameDescription
Asthma ControlEach month throughout the study completion, an average of 2 years (24 months)Asthma Control Test (ACT) is a 5-item clinically validated survey, which is designed to measure the multi-dimensional nature of asthma control, including asthma symptoms, utilization of rescue medications, and the impact of asthma on daily functioning. The ACT score ranges from 5 (poor control of asthma) to 25 (complete control of asthma)

Secondary

MeasureTime frameDescription
Health-Related Quality of LifeBaseline (July 2017) and end-line (March 2020, end of study completion)12-Item Short Form Survey (SF-12) measures eight concepts commonly represented in widely used surveys: general health, physical functioning, bodily pain, vitality (energy/fatigue), social functioning, role limitations due to physical and emotional problems, and mental health (psychological distress and psychological well-being). Both the SF-12 physical (PCS) and mental (MCS) component summary scales use norm-based scoring, 0-100, with higher scores indicating better physical and mental health functioning.
StressBaseline (July 2017) and end-line (March 2020, end of study completion)Perceived Stress Scale (PSS) is a 10-item psychological assessment to understand how unpredictable, uncontrollable, and overloaded participants find their lives. The PSS score ranges from 0 to 40 with higher scores indicating higher perceived stress, and scores ranging from 0 to 13, from 14 to 26, and from 27 to 40 are considered low, moderate, and high perceived stress, respectively.
Asthma medicationsBaseline (July 2017) and end-line (March 2020, end of study completion)Asthma medications via survey
ComorbiditiesBaseline (July 2017) and end-line (March 2020, end of study completion)Comorbidities via survey

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026